All articles tagged with #us pharmaceuticals
Drugmakers plan to raise prices on at least 350 medicines in the U.S., including vaccines and cancer treatments, despite pressure from the Trump administration to lower costs, with some drugs also seeing significant price cuts. The increases are part of ongoing strategies to maximize profits amid regulatory and political scrutiny, while some companies adjust prices to keep pace with inflation and support innovation.
Drugmakers plan to raise prices on at least 350 medicines in the US for 2026, including vaccines and cancer treatments, despite pressure from the Trump administration to lower costs. While some drugs will see price cuts, overall prices are increasing, with companies like Pfizer and GSK citing the need to support innovation and cover costs. These hikes occur even as the US continues to pay significantly more for prescription drugs compared to other developed nations.
Lawmakers are scrutinizing WuXi AppTec, a major Chinese company, over potential ties to the Chinese government, which has raised concerns about the U.S. supply chain for key drugs. The company is deeply involved in the development and manufacturing of crucial therapies for cancer, cystic fibrosis, H.I.V., and other illnesses, and its potential disconnection from U.S. pharmaceutical interests has rattled the biotech industry. Despite its significant role in the U.S. medicine chest, the Congressional spotlight on the company has led to discussions about potential national security threats and the impact of severing ties with the company.